No Impact of Tumor Necrosis-Factor Antagonists on the Joint Manifestations of Sarcoidosis

International Journal of General Medicine - New Zealand
doi 10.2147/ijgm.s44542
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Informa UK Limited

Related search

Tumor Necrosis Factor-Α Production by Blood Mononuclear Cells in Different Manifestations of Sarcoidosis

Pulmonologiya
PulmonaryRespiratory Medicine
2013English

Tumor Necrosis Factor-Alpha Inhibitor Treatment for Sarcoidosis

Therapeutics and Clinical Risk Management
2008English

Tumor Necrosis Factor Α Antagonists in the Treatment of the Patients With Rheumatoid Arthritis

Reumatologia
RheumatologyAllergyImmunology
2012English

437 Efficacy and Safety of Tumor Necrosis Factor Inhibitors in Cutaneous Sarcoidosis: A Systematic Review

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Tumor Necrosis Factor

2004English

Impact of Industry Payments on Prescribing Patterns for Tumor Necrosis Factor Inhibitors Among Medicare Beneficiaries

Journal of General Internal Medicine
Internal Medicine
2018English

Preliminary Studies on Tumor Necrosis Factor (TNF)

Acta Crystallographica Section A Foundations of Crystallography
1987English

Php100 - Utilizations and Expenditures of Tumor Necrosis Factor Antagonists in Medicare Part D: Cross- Sectional Study (2014-2015)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Redox Regulation of Tumor Necrosis Factor Signaling

Antioxidants and Redox Signaling
Cell BiologyMolecular BiologyBiochemistryClinical BiochemistryMedicinePhysiology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy